Market Overview:
The global Pharmacovigilance and Drug Safety Software Market was valued at USD 127.18 million in 2016 and is projected to reach USD 222.83 million by 2025, growing at a CAGR of 6.43% from 2017 to 2025.
Pharmacovigilance software is a drug safety management software solution that supports case management, report preparation, electronic submissions and benefit & risk management as per the guidelines set by ICH, FDA, EMA and other national authorities.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing drug discoveries and technical advancements
1.2 Growing cases of chronic diseases
1.3 Growing geriatric population
1.4 High reports of Drug reactions
1.5 Government safety concerns towards adverse drug results
2. Market Restraints
2.1 Lack of regulations
2.2 Lack of pharmacovigilance professionals
Market Segmentation:
1. Global Pharmacovigilance and Drug Safety Software Market, by Delivery:
1.1 On-Premise Delivery Mode
1.2 On-Demand/Cloud Based (Saas) Delivery Mode
2. Global Pharmacovigilance and Drug Safety Software Market, by Functionality:
2.1 Adverse Event Reporting Software
2.2 Drug Safety Audits Software
2.3 Issue Tracking Software
2.4 Fully Integrated Software
3. Global Pharmacovigilance and Drug Safety Software Market, by End User:
3.1 Pharma and Biotech Companies
3.2 Contract Research Organizations (CROS)
3.3 Business Process Outsourcing (BPO) Firms
3.4 Other Pharmacovigilance Service Providers
4. Global Pharmacovigilance and Drug Safety Software Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. AB-Cube
2. Arisglobal
3. Extedo GMBH.
4. Ennov.
5. Online Business Applications, Inc
6. Oracle Corporation.
7. Sarjen Systems Pvt. Ltd
8. Sparta Systems, Inc
9. United Biosource Corporation
10. Umbra Global
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Pharmacovigilance and Drug Safety Software Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY DELIVERY
5.1 Overview
5.2 On-Premise Delivery Mode
5.3 On-Demand/Cloud Based (Saas) Delivery Mode
6 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY FUNCTIONALITY
6.1 Overview
6.2 Adverse Event Reporting Software
6.3 Drug Safety Audits Software
6.4 Issue Tracking Software
6.5 Fully Integrated Software
7 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY END USER
7.1 Overview
7.2 Pharma and Biotech Companies
7.3 Contract Research Organizations (CROS)
7.4 Business Process Outsourcing (BPO) Firms
7.5 Other Pharmacovigilance Service Providers
8 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
9 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 AB-Cube
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Arisglobal
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Extedo GMBH
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Ennov
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Online Business Applications, Inc
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Oracle Corporation
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Sarjen Systems Pvt. Ltd
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Sparta Systems, Inc
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 United Biosource Corporation
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Umbra Global
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
11 Appendix
11.1 Related Reports
Price : US$ 3500 |
Date : Dec 2024 |
Category : Services |
Pages : 162 |
Price : US$ 3500 |
Date : Dec 2024 |
Category : Services |
Pages : 156 |
Price : US$ 3500 |
Date : Dec 2024 |
Category : Services |
Pages : 156 |